This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Glaxosmithkline Intellectual Property Development Limited, Glaxosmithkline Intellectual Property (No.2) Limited, Glaxosmithkline LLC. Active years: 2017-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 242 
1 out of 95 
1 out of 358 
Years Active: 2017-2021
Title: The Innovations of John Alexander Brown
Introduction
John Alexander Brown is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic potential. With a total of 4 patents to his name, Brown's work focuses on innovative solutions for treating various diseases.
Latest Patents
Among his latest patents are the benzimidazole derivatives as bromodomain inhibitors. These compounds, defined by specific formulas, have been found to inhibit the binding of the BET family of bromodomain proteins to acetylated lysine residues. This inhibition may have therapeutic applications in treating autoimmune and inflammatory diseases, such as rheumatoid arthritis, as well as certain cancers.
Career Highlights
Throughout his career, John Alexander Brown has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with GlaxoSmithKline Intellectual Property Development Limited and GlaxoSmithKline Intellectual Property (No. 2) Limited. His work in these organizations has contributed to the advancement of medical research and innovation.
Collaborations
Brown has collaborated with several professionals in his field, including Rino Antonio Bit and Dominique Amans. These partnerships have likely enhanced the scope and impact of his research and inventions.
Conclusion
John Alexander Brown's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work has the potential to significantly impact the treatment of various diseases, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile